SMAD2 and pulmonary arterial hypertension: For example, the inhibition of the TGF-β1/Smad2/Smad3 signaling pathway using ML133 reduces the proliferation and migration of human PASMCs [26], and restoring the TGF-BMP balance in PAH models improves vascular remodeling [27].